Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Clinical trial NCT02219789 · COMPLETED
Trial details
- NCT number
- NCT02219789
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-05
- Primary completion
- 2016-03-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.